| 1 |
Public Notice regarding DCGI meeting with Stakeholders Dated 15.04.2024 for 2nd and 4th July 2024 Meeting cancellation |
2024-Jul-01 |
|
176 KB |
| 2 |
Public Notice regarding Draft CDSCO Guidance for Industry on Pharmacovigilance requirements for Human Vaccines Version 2.0 Inviting Stakeholder Comments/suggestions |
2024-May-29 |
|
2746 KB |
| 3 |
Circular- Testing and evaluaion of Medical Devices/ In-Vitro Diagnostics by Medical Devices Testing Laboratory in the Country |
2024-May-29 |
|
429 KB |
| 4 |
DTAB Sub-Committee to examine the proposal to regulate antibiotic and its irrational use date 16 may 2024 |
2024-May-16 |
|
447 KB |
| 5 |
Withdrawal of indication for Olaparib Tablets 100mg and 150mg in the treatment of patient with gBRCA mutution and advanced ovarian cancer who have been treated with three or more prior lines of chemotherapy |
2024-May-16 |
|
768 KB |
| 6 |
List of meetings of Expert Committee for examination of vaccine PSUR 2023-24 |
2024-May-15 |
|
7 KB |
| 7 |
NOC's for manufacture of Unapproved/Banned/New Drugs Solely for Export Purpose |
2024-Apr-30 |
|
454 KB |
| 8 |
Stakeholder consultation for feedback on SEC meetings dated 22.04.2024 |
2024-Apr-22 |
|
272 KB |
| 9 |
Manufacturing and marketing of unapproved drug Meropenam 1gm + EDTA for Injection |
2024-Apr-16 |
|
366 KB |
| 10 |
Public Notice regarding DCGI meeting with Stakeholders Dated 15.04.2024 for 18 April 2024 Meeting cancellation |
2024-Apr-15 |
|
143 KB |
